Pharmena S.A. (WSE:PHR)
Poland
· Delayed Price · Currency is PLN 3.340
+0.020 (0.60%)
Apr 29, 2026, 9:18 AM CET
Pharmena Revenue
In the year 2025, Pharmena had annual revenue of 1.58M PLN with 488.43% growth. Pharmena had revenue of 391.00K in the quarter ending December 31, 2025, with 344.32% growth.
Revenue
1.58M
Revenue Growth
+488.43%
P/S Ratio
23.45
Revenue / Employee
225.29K
Employees
7
Market Cap
36.98M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.58M | 1.31M | 488.43% |
| Dec 31, 2024 | 268.00K | -31.00K | -10.37% |
| Dec 31, 2023 | 299.00K | - | - |
| Dec 31, 2022 | 299.00K | -14.91M | -98.03% |
| Dec 31, 2021 | 15.21M | 5.28M | 53.16% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Pure Biologics | -10.52M |
| Urteste | 1.80M |
| Poltreg | 250.00K |
| NanoGroup | -6.90K |
| Molecure | 6.52M |
| Mabion | 14.81M |
| Synthaverse | 71.76M |
| BIOTON | 282.52M |